HIGH-GRADE NI-CU-PT-PD-ZN-CR-AU-V-TI DISCOVERIES IN THE "RING OF FIRE"

NI 43-101 Update (September 2012): 11.1 Mt @ 1.68% Ni, 0.87% Cu, 0.89 gpt Pt and 3.09 gpt Pd and 0.18 gpt Au (Proven & Probable Reserves) / 8.9 Mt @ 1.10% Ni, 1.14% Cu, 1.16 gpt Pt and 3.49 gpt Pd and 0.30 gpt Au (Inferred Resource)

Free
AGORACOM NEWS FLASH

NEW LISTING ALERT!!!

Awakn Life Sciences to Commence Trading on the NEO Exchange Under the Symbol 'AWKN'

  • Strategic focus on developing and delivering psychedelic medicines to treat Addiction.
  • Strong psychedelic drug development pipeline targeting Addiction.
  • First mover advantage for clinics in the UK and the EU with 400m people and CAD$25TR GDP.
  • The leading research and clinical team in the industry focused on using psychedelics to treat Addiction.
  • Multiple scalable revenue streams across drug development and clinical delivery.

Awakn logoset 300x100

Hub On AGORACOM / Corporate Profile / Recent Interview

 

 

Discussion Forum: Noront Resources
Message Title
Rating
Author / Date
3
Jun 21, 2021 01:20PM
5
Jun 19, 2021 02:31PM
5
Jun 18, 2021 07:16PM
5
Jun 18, 2021 05:06PM
2
Jun 18, 2021 01:33PM